During the past decade, Celal Bayar University Medical Faculty conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Celal Bayar University Medical Faculty" #1 sponsor was "Baxalta now part of Shire" with 2 trials, followed by "Celgene" with 2 trials sponsored, "Arbor Pharmaceuticals, Inc." with 1 trials sponsored, "Ayse Baha" with 1 trials sponsored and "Clovis Oncology, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Celal Bayar University Medical Faculty" #1 collaborator was "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "Foundation Medicine" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Celal Bayar University Medical Faculty" are "Chronic Inflammatory Demyelinating Polyradiculoneuropathy" (2 trials), "COPD" (1 trials), "Complete Response" (1 trials), "Epithelial Ovarian Cancer" (1 trials) and "FIGO Stage III-IV" (1 trials). Many other conditions were trialed in "Celal Bayar University Medical Faculty" in a lesser frequency.

Most popular intervention types in "Celal Bayar University Medical Faculty" are "Drug" (4 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "HYQVIA" (2 trials), "0.25% albumin placebo solution with rHuPH20" (1 trials), "Allopurinol" (1 trials), "Azilsartan Medoxomil High-dose" (1 trials) and "Azilsartan Medoxomil Low-dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Celal Bayar University Medical Faculty" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Celal Bayar University Medical Faculty". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Celal Bayar University Medical Faculty, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Celal Bayar University Medical Faculty, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".